v3.25.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (71,271) $ (12,896)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 418,485 388,391
Gain on investments and sale of affiliate interest (5) (292)
Loss on extinguishment of debt and write-off of deferred financing costs 0 7,035
Amortization of deferred financing costs and discounts (premiums) on indebtedness 3,992 6,893
Share-based compensation expense 15,449 13,757
Deferred income taxes (127,410) 86,595
Decrease in right-of-use assets 11,150 11,488
Allowance for credit losses 16,196 21,998
Other 399 1,510
Change in operating assets and liabilities, net of effects of acquisitions and dispositions:    
Accounts receivable, trade 17,187 20,908
Prepaid expenses and other assets (55,377) (85,655)
Amounts due from and due to affiliates 13,905 15,606
Accounts payable and accrued liabilities 42,958 (94,741)
Increase (Decrease) in Interest Payable, Net (120,856) 29,882
Deferred revenue 18,816 3,056
Interest rate swap contracts 3,865 (13,874)
Net cash provided by operating activities 187,483 399,661
Cash flows from investing activities:    
Capital expenditures (356,124) (336,095)
Payments for acquisitions, net of cash acquired (7,616) 0
Other, net 191 318
Net cash used in investing activities (363,549) (335,777)
Cash flows from financing activities:    
Proceeds from long-term debt 450,000 2,950,000
Repayment of debt (220,014) (2,967,306)
Principal payments on finance lease obligations (17,262) (35,396)
Payment related to acquisition of noncontrolling interest 0 (7,261)
Additions to deferred financing costs 0 (17,138)
Other, net (13,997) (3,775)
Net cash provided by (used in) financing activities 198,727 (80,876)
Net increase (decrease) in cash and cash equivalents 22,661 (16,992)
Effect of exchange rate changes on cash and cash equivalents (54) (612)
Net increase (decrease) in cash, cash equivalents and restricted cash 22,607 (17,604)
Cash, cash equivalents and restricted cash at beginning of year 256,824 302,338
Cash, cash equivalents and restricted cash at end of period $ 279,431 $ 284,734